Back to Search
Start Over
Absorption, Distribution, Metabolism, and Excretion of the Androgen Receptor Inhibitor Enzalutamide in Rats and Dogs
- Source :
- European Journal of Drug Metabolism and Pharmacokinetics. 42:611-626
- Publication Year :
- 2016
- Publisher :
- Springer Science and Business Media LLC, 2016.
-
Abstract
- Enzalutamide is an androgen receptor inhibitor that has been approved in several countries. Absorption, distribution, metabolism, and excretion (ADME) data in animals would facilitate understanding of the efficacy and safety profiles of enzalutamide, but little information has been reported in public. The purpose of this study was to clarify the missing ADME profile in animals.ADME ofPlasma concentrations ofRapid oral absorption was observed in rats and dogs when
- Subjects :
- Male
Drug
medicine.medical_specialty
Metabolic Clearance Rate
Clinical chemistry
media_common.quotation_subject
Administration, Oral
Pharmacology
Oral Mucosal Absorption
030226 pharmacology & pharmacy
Rats, Sprague-Dawley
Excretion
Feces
03 medical and health sciences
chemistry.chemical_compound
Dogs
0302 clinical medicine
Species Specificity
Internal medicine
Nitriles
Phenylthiohydantoin
Androgen Receptor Antagonists
medicine
Animals
Bile
Enzalutamide
Distribution (pharmacology)
Tissue Distribution
Pharmacology (medical)
media_common
ADME
Dose-Response Relationship, Drug
Metabolism
Hepatobiliary Elimination
Androgen receptor
Endocrinology
chemistry
030220 oncology & carcinogenesis
Benzamides
Subjects
Details
- ISSN :
- 21070180 and 03787966
- Volume :
- 42
- Database :
- OpenAIRE
- Journal :
- European Journal of Drug Metabolism and Pharmacokinetics
- Accession number :
- edsair.doi.dedup.....9507d55c70ec2623fb2ecbcfbf815743